SGLT2 Inhibitors Treatment Market Size

SGLT2 Inhibitors Treatment Market size was over USD 5.86 Billion in 2023 and is likely to cross USD 19.06 Billion by the end of 2036, growing at more than 9.5% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of SGLT2 inhibitors treatment is estimated at USD 6.36 Billion. The increasing prevalence of diabetes has fuelled the demand for innovative products, advanced technologies, and personalized solutions.  According to the International Diabetes Federation, nearly 783 million adults will be living with diabetes by the end of 2045.

Government efforts to raise awareness of the disease to help in cure and diagnosis at an earlier stage are anticipated to elevate the market’s growth. Moreover, this is leading to growing awareness among people related to diabetes mellitus, and it’s treatment methods.